Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Autoimmune sleep disorders.
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
Influence of infection on exacerbations of multiple sclerosis.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
12th International Conference on Myasthenia Gravis and Related Disorders
Women's Issues in Multiple Sclerosis.
MicroRNAs: The Role in Autoimmune Inflammation.
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Pages
« first
‹ previous
…
66
67
68
69
70
71
72
73
74
…
next ›
last »